DPL
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Dipna Pharmachem To Raise Up To 999.9 Million Rupees Via Convertible Warrants
Feb 24 (Reuters) - Dipna Pharmachem Ltd DIPN.BO:
DIPNA PHARMACHEM LTD - TO RAISE UP TO 999.9 MILLION RUPEES VIA CONVERTIBLE WARRANTS
Source text: ID:nBSE9ZSkRs
Further company coverage: DIPN.BO
(([email protected];;))
Feb 24 (Reuters) - Dipna Pharmachem Ltd DIPN.BO:
DIPNA PHARMACHEM LTD - TO RAISE UP TO 999.9 MILLION RUPEES VIA CONVERTIBLE WARRANTS
Source text: ID:nBSE9ZSkRs
Further company coverage: DIPN.BO
(([email protected];;))
Dipna Pharmachem Says Keyur Parmar Resigns As CFO
Nov 13 (Reuters) - Dipna Pharmachem Ltd DIPN.BO:
KEYUR PARMAR RESIGNS AS CFO
Source text: ID:nBSE2XGKnt
Further company coverage: DIPN.BO
(([email protected];))
Nov 13 (Reuters) - Dipna Pharmachem Ltd DIPN.BO:
KEYUR PARMAR RESIGNS AS CFO
Source text: ID:nBSE2XGKnt
Further company coverage: DIPN.BO
(([email protected];))
Dipna Pharmachem Withdraws Sub-Division Of Shares
Sept 18 (Reuters) - Dipna Pharmachem Ltd DIPN.BO:
DECIDED TO WITHDRAW SUB-DIVISION OF EQUITY SHARES
Source text for Eikon: ID:nBSE6PC0Rk
Further company coverage: DIPN.BO
(([email protected];))
Sept 18 (Reuters) - Dipna Pharmachem Ltd DIPN.BO:
DECIDED TO WITHDRAW SUB-DIVISION OF EQUITY SHARES
Source text for Eikon: ID:nBSE6PC0Rk
Further company coverage: DIPN.BO
(([email protected];))
Dipna Pharmachem To Consider Raising Of Funds
July 24 (Reuters) - Dipna Pharmachem Ltd DIPN.BO:
TO CONSIDER RAISING OF FUNDS BY ISSUE OF SHARES AND/ OR WARRANTS
Source text for Eikon: ID:nBSE6m461P
Further company coverage: DIPN.BO
(([email protected];;))
July 24 (Reuters) - Dipna Pharmachem Ltd DIPN.BO:
TO CONSIDER RAISING OF FUNDS BY ISSUE OF SHARES AND/ OR WARRANTS
Source text for Eikon: ID:nBSE6m461P
Further company coverage: DIPN.BO
(([email protected];;))
Dipna Pharmachem Approved Sub-Division Of Shares
May 6 (Reuters) - Dipna Pharmachem Ltd DIPN.BO:
APPROVED SUB-DIVISION OF SHARES
APPROVED RAISING OF FUNDS UP TO 180 MILLION RUPEES VIA ISSUE OF WARRANTS
APPROVED RAISING OF FUNDS UPTO 490 MILLION RUPEES BY ISSUE OF SHARES THROUGH PREFERENTIAL ALLOTMENT AGAINST TRADE PAYABLES
DECIDED NOT TO PROCEED WITH PROPOSAL OF ISSUE OF BONUS SHARES
Source text for Eikon: ID:nBSEbgsXWK
Further company coverage: DIPN.BO
(([email protected];;))
May 6 (Reuters) - Dipna Pharmachem Ltd DIPN.BO:
APPROVED SUB-DIVISION OF SHARES
APPROVED RAISING OF FUNDS UP TO 180 MILLION RUPEES VIA ISSUE OF WARRANTS
APPROVED RAISING OF FUNDS UPTO 490 MILLION RUPEES BY ISSUE OF SHARES THROUGH PREFERENTIAL ALLOTMENT AGAINST TRADE PAYABLES
DECIDED NOT TO PROCEED WITH PROPOSAL OF ISSUE OF BONUS SHARES
Source text for Eikon: ID:nBSEbgsXWK
Further company coverage: DIPN.BO
(([email protected];;))
Dipna Pharmachem To Issue Shares Worth Upto 129.7 Million Rupees
Jan 31 (Reuters) - Dipna Pharmachem Ltd DIPN.BO:
APPROVED ISSUE OF SHARES WORTH UPTO 129.7 MILLION RUPEES
Source text for Eikon: ID:nBSEYhm52
Further company coverage: DIPN.BO
(([email protected];))
Jan 31 (Reuters) - Dipna Pharmachem Ltd DIPN.BO:
APPROVED ISSUE OF SHARES WORTH UPTO 129.7 MILLION RUPEES
Source text for Eikon: ID:nBSEYhm52
Further company coverage: DIPN.BO
(([email protected];))
Dipna Pharmachem To Consider Issue Of Shares On Rights Basis
Oct 5 (Reuters) - Dipna Pharmachem Ltd DIPN.BO:
TO CONSIDER ISSUE OF SHARES ON RIGHTS BASIS
Further company coverage: DIPN.BO
(([email protected];))
Oct 5 (Reuters) - Dipna Pharmachem Ltd DIPN.BO:
TO CONSIDER ISSUE OF SHARES ON RIGHTS BASIS
Further company coverage: DIPN.BO
(([email protected];))
Upcoming Events:
Quarterly Results
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Dipna Pharma. do?
Dipna Pharmachem Limited specializes in trading and distributing a wide range of pharmaceutical raw materials including APIs and chemical formulations in the Indian market. Their product portfolio includes 61 APIs and intermediates across various categories.
Who are the competitors of Dipna Pharma.?
Dipna Pharma. major competitors are JFL Life Sciences, Deccan Health Care, Biofil Chem & Pharma, Achyut Healthcare, Makers Laboratories, Ind-Swift, Bharat Immunological. Market Cap of Dipna Pharma. is ₹58 Crs. While the median market cap of its peers are ₹86 Crs.
Is Dipna Pharma. financially stable compared to its competitors?
Dipna Pharma. seems to be less financially stable compared to its competitors. Altman Z score of Dipna Pharma. is 2.29 and is ranked 5 out of its 8 competitors.
Does Dipna Pharma. pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Dipna Pharma. latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Dipna Pharma. allocated its funds?
Companies resources are allocated to majorly unproductive assets like Inventory, Short Term Loans & Advances
How strong is Dipna Pharma. balance sheet?
Balance sheet of Dipna Pharma. is moderately strong.
Is the profitablity of Dipna Pharma. improving?
The profit is oscillating. The profit of Dipna Pharma. is ₹0.83 Crs for TTM, ₹1.09 Crs for Mar 2024 and ₹0.91 Crs for Mar 2023.
Is the debt of Dipna Pharma. increasing or decreasing?
Yes, The net debt of Dipna Pharma. is increasing. Latest net debt of Dipna Pharma. is ₹17.04 Crs as of Sep-24. This is greater than Mar-24 when it was -₹8.3 Crs.
Is Dipna Pharma. stock expensive?
Dipna Pharma. is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA. Latest PE of Dipna Pharma. is 53.46, while 3 year average PE is 24.2. Also latest EV/EBITDA of Dipna Pharma. is 0 while 3yr average is 8.74.
Has the share price of Dipna Pharma. grown faster than its competition?
Dipna Pharma. has given better returns compared to its competitors. Dipna Pharma. has grown at ~14.96% over the last 2yrs while peers have grown at a median rate of 3.36%
Is the promoter bullish about Dipna Pharma.?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Dipna Pharma. is 9.98% and last quarter promoter holding is 9.98%.
Are mutual funds buying/selling Dipna Pharma.?
There is Insufficient data to gauge this.